Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-08-14

Clinical Trial Update: Neuraxial Preservative Free Morphine for Normal Spontaneous Vaginal Delivery [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating neuraxial preservative-free morphine for normal spontaneous vaginal delivery has completed and results were posted in 2024.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Morphine (neuraxial preservative-free formulation) (Morphine)

Snippet

Sponsor: Icahn School of Medicine at Mount Sinai | Conditions: Postpartum Pain, Postpartum Depression | Phase 4 | Status: COMPLETED | Results posted: 2024-08-14